chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Pain in arm; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Pain in arm) in a 65-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     Concomitant products included mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination, PREDNISONE.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm). At the time of the report, PAIN IN EXTREMITY (Pain in arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided by the reporter.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Gastrooesophageal reflux disease
Clinical narrative: This spontaneous case was reported by a patient and describes the occurrence of GASTROOESOPHAGEAL REFLUX DISEASE (Acid reflux) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038C21A and 046B21A) for COVID-19 vaccination. No Medical History information was reported. On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced GASTROOESOPHAGEAL REFLUX DISEASE (Acid reflux). On 16-May-2021, GASTROOESOPHAGEAL REFLUX DISEASE (Acid reflux) had resolved.  No concomitant medications were reported. No treatment information was provided. This case was linked to MOD-2021-162370.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Fever; This spontaneous case was reported by a patient and describes the occurrence of PYREXIA (Fever) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.   In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2021, the patient experienced PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, PYREXIA (Fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-May-2021, SARS-CoV-2 test positive: positive (Positive) positive.         The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments  Treatment medication was not provided. Concomitant product was not provided   This case was linked to US-MODERNATX, INC.-MOD-2021-162161 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-162161:crosslink
Sex: U
Vaccine: COVID19
Symptoms: Rash macular
Clinical narrative: blotchy rash; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (blotchy rash) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH MACULAR (blotchy rash). At the time of the report, RASH MACULAR (blotchy rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications and treatment information were reported.
Sex: U
Vaccine: COVID19
Symptoms: Chromaturia, Constipation, Decreased appetite, Musculoskeletal discomfort
Clinical narrative: Discomfort in lower back; loss of appetite; orange urine; constipation; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL DISCOMFORT (Discomfort in lower back), DECREASED APPETITE (loss of appetite), CHROMATURIA (orange urine) and CONSTIPATION (constipation) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 17-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL DISCOMFORT (Discomfort in lower back), DECREASED APPETITE (loss of appetite), CHROMATURIA (orange urine) and CONSTIPATION (constipation). At the time of the report, MUSCULOSKELETAL DISCOMFORT (Discomfort in lower back), DECREASED APPETITE (loss of appetite), CHROMATURIA (orange urine) and CONSTIPATION (constipation) outcome was unknown.            No relevant concomitant medications were reported.  No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Burning sensation, Pain in extremity, Pruritus
Clinical narrative: my hands burn; my hands itch; my hands hurt; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of BURNING SENSATION (my hands burn), PRURITUS (my hands itch) and PAIN IN EXTREMITY (my hands hurt) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced BURNING SENSATION (my hands burn), PRURITUS (my hands itch) and PAIN IN EXTREMITY (my hands hurt). At the time of the report, BURNING SENSATION (my hands burn), PRURITUS (my hands itch) and PAIN IN EXTREMITY (my hands hurt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Tachycardia
Clinical narrative: Tachycardia; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (Tachycardia) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 UNK. On an unknown date, the patient experienced TACHYCARDIA (Tachycardia). At the time of the report, TACHYCARDIA (Tachycardia) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications and treatment medications was reported.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Cough, Wheezing
Clinical narrative: Coughing up mucus/Coughing through the night; Wheezing; This spontaneous case was reported by a patient and describes the occurrence of COUGH (Coughing up mucus/Coughing through the night) and WHEEZING (Wheezing) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Not Provided) for COVID-19 vaccination.     The patient's past medical history included No medical history.    On 27-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Other) at an unspecified dose. On an unknown date, the patient experienced COUGH (Coughing up mucus/Coughing through the night) and WHEEZING (Wheezing). At the time of the report, WHEEZING (Wheezing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Other) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Other), the reporter did not provide any causality assessments.   This case was linked to US-MODERNATX, INC.-MOD-2021-162367 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-162367:Linked to Husband case
Sex: U
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: tested positive today for Covid; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive today for Covid) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-May-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive today for Covid). At the time of the report, SARS-COV-2 TEST POSITIVE (tested positive today for Covid) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Exposure via breast milk, Headache, Myalgia, Vaccination site erythema
Clinical narrative: it got worse; site has fever (warm to touch); looks like a circle (small circle, half dollar); it is hard; red ring on left arm (where she received the vaccine); little bit of headache; sore arm/a little sore; breastfeeding; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE WARMTH (site has fever (warm to touch)), ERYTHEMA (looks like a circle (small circle, half dollar)), EXPOSURE VIA BREAST MILK (breastfeeding), VACCINATION SITE INDURATION (it is hard) and VACCINATION SITE ERYTHEMA (red ring on left arm (where she received the vaccine)) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Hydrocodone and Bactrim). Concomitant products included DULOXETINE HYDROCHLORIDE (CYMBALTA) for an unknown indication.    On 10-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, the patient experienced EXPOSURE VIA BREAST MILK (breastfeeding), HEADACHE (little bit of headache) and MYALGIA (sore arm/a little sore). On 20-May-2021, the patient experienced VACCINATION SITE ERYTHEMA (red ring on left arm (where she received the vaccine)). On 21-May-2021, the patient experienced VACCINATION SITE WARMTH (site has fever (warm to touch)), ERYTHEMA (looks like a circle (small circle, half dollar)) and VACCINATION SITE INDURATION (it is hard). On an unknown date, the patient experienced VACCINATION SITE PAIN (it got worse). At the time of the report, VACCINATION SITE WARMTH (site has fever (warm to touch)), ERYTHEMA (looks like a circle (small circle, half dollar)), EXPOSURE VIA BREAST MILK (breastfeeding), VACCINATION SITE INDURATION (it is hard), VACCINATION SITE ERYTHEMA (red ring on left arm (where she received the vaccine)), HEADACHE (little bit of headache), MYALGIA (sore arm/a little sore) and VACCINATION SITE PAIN (it got worse) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications include Cymbalta   Reporter did not allow further contact
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site induration, Vaccination site pain, Vaccination site warmth
Clinical narrative: it got worse; site has fever (warm to touch); looks like a circle (small circle, half dollar); it is hard; red ring on left arm (where she received the vaccine); little bit of headache; sore arm/a little sore; breastfeeding; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE WARMTH (site has fever (warm to touch)), ERYTHEMA (looks like a circle (small circle, half dollar)), EXPOSURE VIA BREAST MILK (breastfeeding), VACCINATION SITE INDURATION (it is hard) and VACCINATION SITE ERYTHEMA (red ring on left arm (where she received the vaccine)) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Hydrocodone and Bactrim). Concomitant products included DULOXETINE HYDROCHLORIDE (CYMBALTA) for an unknown indication.    On 10-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, the patient experienced EXPOSURE VIA BREAST MILK (breastfeeding), HEADACHE (little bit of headache) and MYALGIA (sore arm/a little sore). On 20-May-2021, the patient experienced VACCINATION SITE ERYTHEMA (red ring on left arm (where she received the vaccine)). On 21-May-2021, the patient experienced VACCINATION SITE WARMTH (site has fever (warm to touch)), ERYTHEMA (looks like a circle (small circle, half dollar)) and VACCINATION SITE INDURATION (it is hard). On an unknown date, the patient experienced VACCINATION SITE PAIN (it got worse). At the time of the report, VACCINATION SITE WARMTH (site has fever (warm to touch)), ERYTHEMA (looks like a circle (small circle, half dollar)), EXPOSURE VIA BREAST MILK (breastfeeding), VACCINATION SITE INDURATION (it is hard), VACCINATION SITE ERYTHEMA (red ring on left arm (where she received the vaccine)), HEADACHE (little bit of headache), MYALGIA (sore arm/a little sore) and VACCINATION SITE PAIN (it got worse) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications include Cymbalta   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Chest pain, Myalgia
Clinical narrative: Chest pain; Arm pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pain) and MYALGIA (Arm pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (Chest pain) and MYALGIA (Arm pain). At the time of the report, CHEST PAIN (Chest pain) and MYALGIA (Arm pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported. No treatment information reported.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Hyperhidrosis, Myalgia, Nausea
Clinical narrative: Body sweat; Nausea; Chills; Body ache; Tired; Fever (no temperature given); This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Body sweat), NAUSEA (Nausea), CHILLS (Chills), MYALGIA (Body ache) and FATIGUE (Tired) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. C2621A and C47B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history reported.  Concomitant products included OXCARBAZEPINE (OXTELLAR XR) for Seizure.   On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-May-2021, the patient experienced HYPERHIDROSIS (Body sweat), NAUSEA (Nausea), CHILLS (Chills), MYALGIA (Body ache), FATIGUE (Tired) and PYREXIA (Fever (no temperature given)). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, HYPERHIDROSIS (Body sweat), NAUSEA (Nausea), CHILLS (Chills), MYALGIA (Body ache) and FATIGUE (Tired) had not resolved and PYREXIA (Fever (no temperature given)) had resolved.            This case was linked to MOD-2021-162358 (Patient Link).
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Body sweat; Nausea; Chills; Body ache; Tired; Fever (no temperature given); This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Body sweat), NAUSEA (Nausea), CHILLS (Chills), MYALGIA (Body ache) and FATIGUE (Tired) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. C2621A and C47B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history reported.  Concomitant products included OXCARBAZEPINE (OXTELLAR XR) for Seizure.   On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-May-2021, the patient experienced HYPERHIDROSIS (Body sweat), NAUSEA (Nausea), CHILLS (Chills), MYALGIA (Body ache), FATIGUE (Tired) and PYREXIA (Fever (no temperature given)). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, HYPERHIDROSIS (Body sweat), NAUSEA (Nausea), CHILLS (Chills), MYALGIA (Body ache) and FATIGUE (Tired) had not resolved and PYREXIA (Fever (no temperature given)) had resolved.            This case was linked to MOD-2021-162358 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Pain of skin
Clinical narrative: sore skin; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN OF SKIN (sore skin) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No medical history was reported.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced PAIN OF SKIN (sore skin). At the time of the report, PAIN OF SKIN (sore skin) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. No treatment was reported.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm hurt so bad after the shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. No medical history was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced VACCINATION SITE PAIN (Arm hurt so bad after the shot). At the time of the report, VACCINATION SITE PAIN (Arm hurt so bad after the shot) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. No concomitant medication was reported , No treatment medicatipn was reported. Reporter did not allow further contact.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Peripheral swelling, Urticaria
Clinical narrative: swollen left arm; welt on her left arm; headache; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen left arm), URTICARIA (welt on her left arm) and HEADACHE (headache) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced PERIPHERAL SWELLING (swollen left arm), URTICARIA (welt on her left arm) and HEADACHE (headache). On 15-Apr-2021, URTICARIA (welt on her left arm) and HEADACHE (headache) had resolved. At the time of the report, PERIPHERAL SWELLING (swollen left arm) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant and treatment information was provided by reporter.
Sex: U
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: Feet swelling; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Feet swelling) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported by the reporter.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Feet swelling). At the time of the report, PERIPHERAL SWELLING (Feet swelling) outcome was unknown.            No concomitant medication included.  No treatment medication included.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Chest discomfort
Clinical narrative: heaviness in the chest; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (heaviness in the chest) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST DISCOMFORT (heaviness in the chest). At the time of the report, CHEST DISCOMFORT (heaviness in the chest) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications and treatment information were reported.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Pruritus
Clinical narrative: i have like a bruise under both breasts; it doesn´t hurt, but there was itching; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (i have like a bruise under both breasts) and PRURITUS (it doesn´t hurt, but there was itching) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-May-2021, the patient experienced CONTUSION (i have like a bruise under both breasts) and PRURITUS (it doesn´t hurt, but there was itching). The patient was treated with HYDROCORTISONE on 20-May-2021 for Itching, at an unspecified dose and frequency. At the time of the report, CONTUSION (i have like a bruise under both breasts) and PRURITUS (it doesn´t hurt, but there was itching) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 immunisation
Clinical narrative: Moderna as first dose, Pfizer as second dose; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 IMMUNISATION (Moderna as first dose, Pfizer as second dose) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, the patient experienced COVID-19 IMMUNISATION (Moderna as first dose, Pfizer as second dose). On 21-May-2021, COVID-19 IMMUNISATION (Moderna as first dose, Pfizer as second dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment information was unknown.   Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: Added contact information (address, institution) and patient initials.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore arm from the first dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm from the first dose) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. C47B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included OXCARBAZEPINE (OXTELLAR XR) for Seizure.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced VACCINATION SITE PAIN (Sore arm from the first dose). At the time of the report, VACCINATION SITE PAIN (Sore arm from the first dose) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No treatment medications provided by the reporter.      This case was linked to MOD-2021-162348 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Follow-up received on 20-JUL-2021 contains no significant information
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Arthritis, Chest discomfort, Erythema, Facial pain, Gait disturbance
Clinical narrative: Unable to walk; Limping; Congestion in the chest; Little redness on the face; Little soreness on the face; Slight Headache; Bad arthritis reaction in hands, neck; Bad arthritis reaction in hands, neck; Bad gout reaction in all joints, big toe, feet, hands, wrist; This spontaneous case was reported by a patient and describes the occurrence of CHEST DISCOMFORT (Congestion in the chest), ERYTHEMA (Little redness on the face), FACIAL PAIN (Little soreness on the face), ARTHRITIS (Bad arthritis reaction in hands, neck) and GAIT INABILITY (Unable to walk) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Gout. Concurrent medical conditions included Diabetes, Blood pressure high and Cholesterol total abnormal NOS. Concomitant products included METFORMIN for an unknown indication.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced ARTHRITIS (Bad arthritis reaction in hands, neck), SPONDYLITIS (Bad arthritis reaction in hands, neck) and GOUT (Bad gout reaction in all joints, big toe, feet, hands, wrist). On 01-May-2021, the patient experienced CHEST DISCOMFORT (Congestion in the chest), ERYTHEMA (Little redness on the face), FACIAL PAIN (Little soreness on the face) and HEADACHE (Slight Headache). On an unknown date, the patient experienced GAIT INABILITY (Unable to walk) and GAIT DISTURBANCE (Limping). The patient was treated with IBUPROFEN at a dose of 1 dosage form. On 03-May-2021, CHEST DISCOMFORT (Congestion in the chest), ERYTHEMA (Little redness on the face), FACIAL PAIN (Little soreness on the face) and HEADACHE (Slight Headache) had resolved. At the time of the report, ARTHRITIS (Bad arthritis reaction in hands, neck), GAIT INABILITY (Unable to walk), GAIT DISTURBANCE (Limping), SPONDYLITIS (Bad arthritis reaction in hands, neck) and GOUT (Bad gout reaction in all joints, big toe, feet, hands, wrist) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient reported that he experienced COVID -like symptoms which included slight headache, congestion in chest, little redness and soreness in the face. Patient reported that he soaked in bathtub for 5 hours.  The concomitant medication included 2 unspecified medications for high blood pressure and 1 unspecified medication for cholesterol.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Gait inability, Gout, Headache, Spondylitis
Clinical narrative: Unable to walk; Limping; Congestion in the chest; Little redness on the face; Little soreness on the face; Slight Headache; Bad arthritis reaction in hands, neck; Bad arthritis reaction in hands, neck; Bad gout reaction in all joints, big toe, feet, hands, wrist; This spontaneous case was reported by a patient and describes the occurrence of CHEST DISCOMFORT (Congestion in the chest), ERYTHEMA (Little redness on the face), FACIAL PAIN (Little soreness on the face), ARTHRITIS (Bad arthritis reaction in hands, neck) and GAIT INABILITY (Unable to walk) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Gout. Concurrent medical conditions included Diabetes, Blood pressure high and Cholesterol total abnormal NOS. Concomitant products included METFORMIN for an unknown indication.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced ARTHRITIS (Bad arthritis reaction in hands, neck), SPONDYLITIS (Bad arthritis reaction in hands, neck) and GOUT (Bad gout reaction in all joints, big toe, feet, hands, wrist). On 01-May-2021, the patient experienced CHEST DISCOMFORT (Congestion in the chest), ERYTHEMA (Little redness on the face), FACIAL PAIN (Little soreness on the face) and HEADACHE (Slight Headache). On an unknown date, the patient experienced GAIT INABILITY (Unable to walk) and GAIT DISTURBANCE (Limping). The patient was treated with IBUPROFEN at a dose of 1 dosage form. On 03-May-2021, CHEST DISCOMFORT (Congestion in the chest), ERYTHEMA (Little redness on the face), FACIAL PAIN (Little soreness on the face) and HEADACHE (Slight Headache) had resolved. At the time of the report, ARTHRITIS (Bad arthritis reaction in hands, neck), GAIT INABILITY (Unable to walk), GAIT DISTURBANCE (Limping), SPONDYLITIS (Bad arthritis reaction in hands, neck) and GOUT (Bad gout reaction in all joints, big toe, feet, hands, wrist) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient reported that he experienced COVID -like symptoms which included slight headache, congestion in chest, little redness and soreness in the face. Patient reported that he soaked in bathtub for 5 hours.  The concomitant medication included 2 unspecified medications for high blood pressure and 1 unspecified medication for cholesterol.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (fatigue). At the time of the report, FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant  information was reported No Treatment information was reported
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Arthralgia, Chills, Diarrhoea, Fatigue
Clinical narrative: stomach pain; diarrhea (ongoing); sharp pain in the right side of her body (ongoing) got worse that night; pain starts in the middle of her stomach and runs down into her right hip and right lower side (in; chills; sweats; "almost paralyzed"; "really super sick"; "down for two days"; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL ("almost paralyzed"), ILLNESS ("really super sick"), FATIGUE ("down for two days"), CHILLS (chills) and HYPERHIDROSIS (sweats) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002C21A and 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Overweight.   On 06-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 08-May-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to dosage form. On 06-May-2021, the patient experienced FEELING ABNORMAL ("almost paralyzed"), ILLNESS ("really super sick") and FATIGUE ("down for two days"). On 08-May-2021, the patient experienced CHILLS (chills) and HYPERHIDROSIS (sweats). On 09-May-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach pain), DIARRHOEA (diarrhea (ongoing)), PAIN (sharp pain in the right side of her body (ongoing) got worse that night) and ARTHRALGIA (pain starts in the middle of her stomach and runs down into her right hip and right lower side (in). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of UNK dosage form. On 08-May-2021, FEELING ABNORMAL ("almost paralyzed"), ILLNESS ("really super sick") and FATIGUE ("down for two days") had resolved. At the time of the report, CHILLS (chills), HYPERHIDROSIS (sweats), ABDOMINAL PAIN UPPER (stomach pain) and ARTHRALGIA (pain starts in the middle of her stomach and runs down into her right hip and right lower side (in) outcome was unknown and DIARRHOEA (diarrhea (ongoing)) and PAIN (sharp pain in the right side of her body (ongoing) got worse that night) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported.   This case was linked to MOD-2021-162351 (Patient Link).
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Hyperhidrosis, Illness, Pain
Clinical narrative: stomach pain; diarrhea (ongoing); sharp pain in the right side of her body (ongoing) got worse that night; pain starts in the middle of her stomach and runs down into her right hip and right lower side (in; chills; sweats; "almost paralyzed"; "really super sick"; "down for two days"; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL ("almost paralyzed"), ILLNESS ("really super sick"), FATIGUE ("down for two days"), CHILLS (chills) and HYPERHIDROSIS (sweats) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002C21A and 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Overweight.   On 06-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 08-May-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to dosage form. On 06-May-2021, the patient experienced FEELING ABNORMAL ("almost paralyzed"), ILLNESS ("really super sick") and FATIGUE ("down for two days"). On 08-May-2021, the patient experienced CHILLS (chills) and HYPERHIDROSIS (sweats). On 09-May-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach pain), DIARRHOEA (diarrhea (ongoing)), PAIN (sharp pain in the right side of her body (ongoing) got worse that night) and ARTHRALGIA (pain starts in the middle of her stomach and runs down into her right hip and right lower side (in). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of UNK dosage form. On 08-May-2021, FEELING ABNORMAL ("almost paralyzed"), ILLNESS ("really super sick") and FATIGUE ("down for two days") had resolved. At the time of the report, CHILLS (chills), HYPERHIDROSIS (sweats), ABDOMINAL PAIN UPPER (stomach pain) and ARTHRALGIA (pain starts in the middle of her stomach and runs down into her right hip and right lower side (in) outcome was unknown and DIARRHOEA (diarrhea (ongoing)) and PAIN (sharp pain in the right side of her body (ongoing) got worse that night) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported.   This case was linked to MOD-2021-162351 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: administered 12 expired vials to patients; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered 12 expired vials to patients) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered 12 expired vials to patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered 12 expired vials to patients) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were reported. No Treatment was reported.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age, Vaccination site pain
Clinical narrative: Soreness of the arm after the 1st dose; 12 year old patient got the 1st dose of Moderna COVID-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness of the arm after the 1st dose) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (12 year old patient got the 1st dose of Moderna COVID-19 vaccine) in a 12-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 23-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-May-2021, the patient experienced VACCINATION SITE PAIN (Soreness of the arm after the 1st dose) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (12 year old patient got the 1st dose of Moderna COVID-19 vaccine). At the time of the report, VACCINATION SITE PAIN (Soreness of the arm after the 1st dose) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (12 year old patient got the 1st dose of Moderna COVID-19 vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Chills, Decreased appetite, Hyperhidrosis
Clinical narrative: runny nose; low energy; sweating; unable to move joints; nausea; Vomiting; chills; 103F fever; loss of appetite/Not eating/Not drinking; arm pain; neck pain; shoulder pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain), NECK PAIN (neck pain), DECREASED APPETITE (loss of appetite/Not eating/Not drinking), RHINORRHOEA (runny nose) and ASTHENIA (low energy) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History Information was reported.     On 19-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-May-2021, the patient experienced PAIN IN EXTREMITY (arm pain), NECK PAIN (neck pain) and ARTHRALGIA (shoulder pain). On 20-May-2021, the patient experienced DECREASED APPETITE (loss of appetite/Not eating/Not drinking), ASTHENIA (low energy), HYPERHIDROSIS (sweating), JOINT RANGE OF MOTION DECREASED (unable to move joints), VOMITING (Vomiting) and PYREXIA (103F fever). 20-May-2021, the patient experienced NAUSEA (nausea) and CHILLS (chills). On 21-May-2021, the patient experienced RHINORRHOEA (runny nose). The patient was treated with IBUPROFEN at a dose of 1 dosage form; ACETYLSALICYLIC ACID, CAFFEINE, SALICYLAMIDE (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;SALICYLAMIDE]) at a dose of 1 dosage form and DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (DAYQUIL) at a dose of 1 dosage form. On 20-May-2021, PYREXIA (103F fever) had resolved. At the time of the report, PAIN IN EXTREMITY (arm pain), NECK PAIN (neck pain), DECREASED APPETITE (loss of appetite/Not eating/Not drinking), RHINORRHOEA (runny nose), ASTHENIA (low energy), HYPERHIDROSIS (sweating), JOINT RANGE OF MOTION DECREASED (unable to move joints), NAUSEA (nausea), ARTHRALGIA (shoulder pain), VOMITING (Vomiting) and CHILLS (chills) outcome was unknown.            No concomitant medications were reported.  Action taken with mRNA-1273 in response to the event was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Joint range of motion decreased, Nausea, Neck pain, Pain in extremity, Pyrexia
Clinical narrative: runny nose; low energy; sweating; unable to move joints; nausea; Vomiting; chills; 103F fever; loss of appetite/Not eating/Not drinking; arm pain; neck pain; shoulder pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain), NECK PAIN (neck pain), DECREASED APPETITE (loss of appetite/Not eating/Not drinking), RHINORRHOEA (runny nose) and ASTHENIA (low energy) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History Information was reported.     On 19-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-May-2021, the patient experienced PAIN IN EXTREMITY (arm pain), NECK PAIN (neck pain) and ARTHRALGIA (shoulder pain). On 20-May-2021, the patient experienced DECREASED APPETITE (loss of appetite/Not eating/Not drinking), ASTHENIA (low energy), HYPERHIDROSIS (sweating), JOINT RANGE OF MOTION DECREASED (unable to move joints), VOMITING (Vomiting) and PYREXIA (103F fever). 20-May-2021, the patient experienced NAUSEA (nausea) and CHILLS (chills). On 21-May-2021, the patient experienced RHINORRHOEA (runny nose). The patient was treated with IBUPROFEN at a dose of 1 dosage form; ACETYLSALICYLIC ACID, CAFFEINE, SALICYLAMIDE (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;SALICYLAMIDE]) at a dose of 1 dosage form and DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (DAYQUIL) at a dose of 1 dosage form. On 20-May-2021, PYREXIA (103F fever) had resolved. At the time of the report, PAIN IN EXTREMITY (arm pain), NECK PAIN (neck pain), DECREASED APPETITE (loss of appetite/Not eating/Not drinking), RHINORRHOEA (runny nose), ASTHENIA (low energy), HYPERHIDROSIS (sweating), JOINT RANGE OF MOTION DECREASED (unable to move joints), NAUSEA (nausea), ARTHRALGIA (shoulder pain), VOMITING (Vomiting) and CHILLS (chills) outcome was unknown.            No concomitant medications were reported.  Action taken with mRNA-1273 in response to the event was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Rhinorrhoea, Vomiting
Clinical narrative: runny nose; low energy; sweating; unable to move joints; nausea; Vomiting; chills; 103F fever; loss of appetite/Not eating/Not drinking; arm pain; neck pain; shoulder pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain), NECK PAIN (neck pain), DECREASED APPETITE (loss of appetite/Not eating/Not drinking), RHINORRHOEA (runny nose) and ASTHENIA (low energy) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History Information was reported.     On 19-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-May-2021, the patient experienced PAIN IN EXTREMITY (arm pain), NECK PAIN (neck pain) and ARTHRALGIA (shoulder pain). On 20-May-2021, the patient experienced DECREASED APPETITE (loss of appetite/Not eating/Not drinking), ASTHENIA (low energy), HYPERHIDROSIS (sweating), JOINT RANGE OF MOTION DECREASED (unable to move joints), VOMITING (Vomiting) and PYREXIA (103F fever). 20-May-2021, the patient experienced NAUSEA (nausea) and CHILLS (chills). On 21-May-2021, the patient experienced RHINORRHOEA (runny nose). The patient was treated with IBUPROFEN at a dose of 1 dosage form; ACETYLSALICYLIC ACID, CAFFEINE, SALICYLAMIDE (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;SALICYLAMIDE]) at a dose of 1 dosage form and DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (DAYQUIL) at a dose of 1 dosage form. On 20-May-2021, PYREXIA (103F fever) had resolved. At the time of the report, PAIN IN EXTREMITY (arm pain), NECK PAIN (neck pain), DECREASED APPETITE (loss of appetite/Not eating/Not drinking), RHINORRHOEA (runny nose), ASTHENIA (low energy), HYPERHIDROSIS (sweating), JOINT RANGE OF MOTION DECREASED (unable to move joints), NAUSEA (nausea), ARTHRALGIA (shoulder pain), VOMITING (Vomiting) and CHILLS (chills) outcome was unknown.            No concomitant medications were reported.  Action taken with mRNA-1273 in response to the event was not applicable.